A small study shows cognitive improvements in patients with AD following treatment with an in-home gamma sensory stimulation ...

MIT researchers say they've developed microscopic "circulatronics" technology that could one day provide noninvasive brain ...

The only approved treatments for Alzheimer’s disease are medications with limited effectiveness and a risk of severe, sometimes deadly, side effects. That’s why scientists search for therapies that ...

MIT researchers are using living cells to target diseased brain areas and deliver tiny electronic devices that can modulate ...

The FDA has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants.

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform ...

MAITLAND, Fla., Nov. 5, 2025 /PRNewswire/ -- Those seeking help with depression or other mental health concerns can access breakthrough, medication-free support at Foundations at Maitland. The ...

WEDNESDAY, Sept. 10, 2025 (HealthDay News) — Deep brain stimulation has shown promise in treating conditions ranging from epilepsy and Parkinson’s disease to cluster headaches, depression and ...

NORTHVILLE, Mich., Oct. 1, 2025 /PRNewswire/ -- For individuals battling depression or anxiety there's hope from a breakthrough technology, now available at Northville Beauty Spa in Northville, ...

There is no cure for Parkinson's, and over one million people have the disease in the United States alone. However, deep brain stimulation (DBS) has been used to treat this and other neurological ...

The procedure helps many keep movement disorders at bay but also poses dangers. May 1, 2010— -- Adding deep brain stimulation to medical therapy for Parkinson's disease improved symptoms and ...

The U.S. Food and Drug Administration cleared Flow Neuroscience’s at-home electrical stimulation headset for adults with moderate-to-severe depression A trial of 174 people found the device led to ...